Why all women should freeze their eggs

Current Opinion in Obstetrics and Gynecology

Volumn 28, Issue 3, 2016, Pages 206-210

  Cobo, Ana ^a   García Velasco, Juan Antonio ^a  

^a INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

Author keywords

elective fertility preservation; fertility preservation; maternal age; oocyte vitrification; survival rate

Indexed keywords

BIRTH RATE; CLINICAL EFFECTIVENESS; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DEVELOPMENTAL STAGE; ELECTIVE FERTILITY PRESERVATION; EMBRYO DEVELOPMENT; EMBRYO TRANSFER; ENDOMETRIOSIS; FEMALE INFERTILITY; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; HUMAN; LIVE BIRTH; MATERNAL AGE; MOTIVATION; MULTICENTER STUDY (TOPIC); OOCYTE VITRIFICATION; OVARIAN RESERVE; OVARIECTOMY; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME; VITRIFICATION; ADULT; CRYOPRESERVATION; FEMALE; IN VITRO FERTILIZATION; INFERTILITY THERAPY; OOCYTE; PREGNANCY; PROCEDURES;

ADULT; CRYOPRESERVATION; FEMALE; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; HUMANS; OOCYTES; PREGNANCY; PREGNANCY RATE; REPRODUCTIVE TECHNIQUES, ASSISTED; VITRIFICATION;

EID: 84962052858     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0000000000000269     Document Type: Review

References (47)

1. Cobo A, Domingo J, Pé rez S, et al. Vitrification, an effective new approach to oocyte banking in healthy women, could be applied in cancer patients to preserve their fertility. Clin Transl Oncol 2008; 10: 268-273
2. Dondorp WJ, De Wert GM. Fertility preservation for healthy women: ethical aspects. Hum Reprod 2009; 24: 1779-1785
3. Garcia-Velasco JA, Domingo J, Cobo A, et al. Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications. Fertil Steril 2013; 99: 1994-1999
4. Edad Media a la Maternidad por orden del nacimiento según nacionalidad (española/extranjera) de la madre. [database on the Internet]. [Accessed 9 September 2015]
5. Mertes H, Pennings G. Social egg freezing: for better, not for worse. Reprod Biomed Online 2011; 23: 824-829
6. Cobo A, Garrido N, Crespo J, et al. Accumulation of oocytes: a new strategy for managing low-responder patients. Reprod Biomed Online 2012; 24: 424-432
7. Herrero L, Pareja S, Losada C, et al. Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyperstimulation syndrome. Fertil Steril 2011; 95: 1137-1140
8. Herrero L, Pareja S, Aragones M, et al. Oocyte versus embryo vitrification for delayed embryo transfer: an observational study. Reprod Biomed Online 2014; 29: 567-572
9. The Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril 2013; 99: 37-43
10. Cobo A, Meseguer M, Remohi J, Pellicer A. Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum Reprod 2010; 25: 2239-2246
11. Doyle JO, Richter KS, Lim J, et al. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval. Fertil Steril 2016; 105: 459-466
12. Rudick B, Opper N, Paulson R, et al. The status of oocyte cryopreservation in the United States. Fertil Steril 2010; 94: 2642-2646
13. Cobo A, Garcia-Velasco JA, Coello A, et al. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril 2016; 105: 755-764
14. Mesen TB, Mersereau JE, Kane JB, Steiner AZ. Optimal timing for elective egg freezing. Fertil Steril 2015; 103: 1551-1556
15. Mertes H, Pennings G. Elective oocyte cryopreservation: who should pay?. Hum Reprod 2012; 27: 9-13
16. Stoop D, van der Veen F, Deneyer M, et al. Oocyte banking for anticipated gamete exhaustion (AGE) is a preventive intervention, neither social nor nonmedical. Reprod Biomed Online 2014; 28: 548-551
17. Cobo A, Kuwayama M, Perez S, et al. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril 2008; 89: 1657-1664
18. Rienzi L, Romano S, Albricci L, et al. Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized siblingoocyte study. Hum Reprod 2010; 25: 66-73
19. Parmegiani L, Cognigni GE, Bernardi S, et al. Efficiency of aseptic open vitrification and hermetical cryostorage of human oocytes. Reprod Biomed Online 2011; 23: 505-512
20. Nagy ZP, Chang CC, Shapiro DB, et al. Clinical evaluation of the efficiency of an oocyte donation program using egg cryo-banking. Fertil Steril 2009; 92: 520-526
21. Cobo A, Remohi J, Chang CC, Nagy ZP. Oocyte cryopreservation for donor egg banking. Reprod Biomed Online 2011; 23: 341-346
22. Trokoudes KM, Pavlides C, Zhang X. Comparison outcome of fresh and vitrified donor oocytes in an egg-sharing donation program. Fertil Steril 2011; 95: 1996-2000
23. Garcia JI, Noriega-Portella L, Noriega-Hoces L. Efficacy of oocyte vitrification combined with blastocyst stage transfer in an egg donation program. Hum Reprod 2011; 26: 782-790
24. Stoop D, De Munck N, Jansen E, et al. Clinical validation of a closed vitrification system in an oocyte-donation programme. Reprod Biomed Online 2012; 24: 180-185
25. De Munck N, Santos-Ribeiro S, Stoop D, et al. Open versus closed oocyte vitrification in an oocyte donation programme: a prospective randomized sibling oocyte study. Hum Reprod 2016; 31: 377-384
26. Papatheodorou A, Vanderzwalmen P, Panagiotidis Y, et al. Open versus closed oocyte vitrification system: a prospective randomized sibling-oocyte study. Reprod Biomed Online 2013; 26: 595-602
27. Cobo A, Garrido N, Pellicer A, Remohi J. Six years' experience in ovum donation using vitrified oocytes: report of cumulative outcomes, impact of storage time, and development of a predictive model for oocyte survival rate. Fertil Steril 2015; 104: 1426-1434
28. Rienzi L, Cobo A, Paffoni A, et al. Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study. Hum Reprod 2012; 27: 1606-1612
29. Ubaldi F, Anniballo R, Romano S, et al. Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program. Hum Reprod 2010; 25: 1199-1205
30. Kim TJ, Laufer LR, Hong SW. Vitrification of oocytes produces high pregnancy rates when carried out in fertile women. Fertil Steril 2010; 93: 467-474
31. Cil AP, Bang H, Oktay K. Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-Analysis. Fertil Steril 2013; 100: 492-499
32. Milan M, Cobo AC, Rodrigo L, et al. Redefining advanced maternal age as an indication for preimplantation genetic screening. Reprod Biomed Online 2010; 21: 649-657
33. Leibo SP. Cryopreservation of oocytes and embryos: optimization by theoretical versus empirical analysis. Theriogenology 2008; 69: 37-47
34. Baldwin K, Culley L, Hudson N, et al. Oocyte cryopreservation for social reasons: demographic profile and disposal intentions of UK users. Reprod Biomed Online 2015; 31: 239-245
35. Kim MK, Lee DR, Han JE, et al. Live birth with vitrified-warmed oocytes of a chronic myeloid leukemia patient nine years after allogenic bone marrow transplantation. J Assist Reprod Genet 2011; 28: 1167-1170
36. Alvarez M, Sole M, Devesa M, et al. Live birth using vitrified: warmed oocytes in invasive ovarian cancer: case report and literature review. Reprod Biomed Online 2014; 28: 663-668
37. da Motta EL, Bonavita M, Alegretti JR, et al. Live birth after 6 years of oocyte vitrification in a survivor with breast cancer. J Assist Reprod Genet 2014; 31: 1397-1400
38. Martinez M, Rabadan S, Domingo J, et al. Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer. Reprod Biomed Online 2014; 29: 722-728
39. Cobo A, Garcia-Velasco JA, Domingo J, et al. Is vitrification of oocytes useful for fertility preservation for age-related fertility decline and in cancer patients?. Fertil Steril 2013; 99: 1485-1495
40. Stoop D, Nekkebroeck J, Devroey P. A survey on the intentions and attitudes towards oocyte cryopreservation for nonmedical reasons among women of reproductive age. Hum Reprod 2011; 26: 655-661
41. Hodes-Wertz B, Druckenmiller S, Smith M, Noyes N. What do reproductiveage women who undergo oocyte cryopreservation think about the process as a means to preserve fertility?. Fertil Steril 2013; 100: 1343-1349
42. Friedman D. Perk up: Facebook and Apple now pay for women to freeze eggs. NBC News, available at: http: //www.nbcnews.com/news/us-news/perk-face book-Apple-now-pay-women-freeze-eggs-n225011October 14, 2014. [Accessed September 2015]
43. Mertes H. Does company-sponsored egg freezing promote or confine women's reproductive autonomy?. J Assist Reprod Genet 2015; 32: 1205-1209
44. Lockwood G, Johnson MH. Having it all?. Where are we with 'social' egg freezing today?. Reprod Biomed Online 2015; 31: 126-127
45. Murk W, Seli E. Fertility preservation as a public health issue: an epidemiological perspective. Curr Opin Obstet Gynecol 2011; 23: 143-150
46. Devine K, Stillman RJ, DeCherney AH. Building a family through in vitro fertilization: economic realities. Fertil Steril 2015; 103: 357-358
47. Stoop D. Oocyte vitrification for elective fertility preservation: lessons for patient counseling. Fertil Steril 2016; 105: 603-604